US Patent:
20040029249, Feb 12, 2004
Inventors:
Ernestine Lee - Castro Valley CA, US
April Hafalia - Daly City CA, US
Henry Yue - Sunnyvale CA, US
Preeti Lal - Santa Clara CA, US
Monique Yao - Carmel IN, US
Yan Lu - Mountain View CA, US
Narinder Chawla - Union City CA, US
Bridget Warren - Encinitas CA, US
Dyung Lu - San Jose CA, US
Mariah Baughn - San Leandro CA, US
Angelo Delegeane - Milpitas CA, US
Neil Burford - Durham CT, US
Mark Borowsky - Northampton MA, US
Sally Lee - San Jose CA, US
Yuming Xu - Mountain View CA, US
Jennifer Griffin - Fremont CA, US
Deborah Kallick - Stanford CA, US
Ameena Gandhi - San Francisco CA, US
Chandra Arvizu - San Jose CA, US
Craig Ison - San Jose CA, US
Y Tang - San Jose CA, US
Yalda Azimzai - Oakland CA, US
Vicki Elliott - San Jose CA, US
Anita Swarnakar - San Francisco CA, US
Jayalaxmi Ramkumar - Fremont CA, US
Danniel Nguyen - San Jose CA, US
Catherine Tribouley - San Francisco CA, US
Terence Lo - Foster City CA, US
Janice Au-Young - Brisbane CA, US
Kavitha Thangavelu - Sunnyvale CA, US
Liam Kearney - San Francisco CA, US
International Classification:
C12N009/64
C07H021/04
C12P021/02
C12N005/06
US Classification:
435/226000, 435/069100, 435/320100, 435/325000, 536/023200
Abstract:
The invention provides human proteases (PRTS) and polynucleotides which identify and encode PRTS. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of PRTS.